Sustained-release interleukin-2 following intramuscular injection in rats
- 1 January 1995
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 113 (1), 73-81
- https://doi.org/10.1016/0378-5173(94)00179-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Biological Activity of Urease Formulated in Poloxamer 407 after Intraperitoneal Injection in the RatJournal of Pharmaceutical Sciences, 1992
- Kinetics of sol‐to‐gel transition for poloxamer polyolsJournal of Applied Polymer Science, 1991
- Fate of interleukin‐6 in the ratEuropean Journal of Biochemistry, 1990
- Therapeutic uses of interleukin-2 and lymphokine-activated killer (LAK) cellsBlood Reviews, 1989
- Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2Cancer Immunology, Immunotherapy, 1986
- Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.The Journal of Experimental Medicine, 1985
- Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.The Journal of Experimental Medicine, 1984
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.The Journal of Experimental Medicine, 1982
- The Role of the Kidney in the Metabolism of Plasma ProteinsNephron, 1974